Electrical Safety Testing: IEC 60601

1. Key takeaways

Active medical devices in Myanmar must submit electrical safety and electromagnetic compatibility (EMC) test reports, with the standard system being the IEC 60601 series. This is an additional document requirement exclusive to active devices; passive consumable-type products are not covered by it.

GRZAN note: the scope of this requirement is active medical devices, so determining whether the product is active is the first fork in building the document list. Devices containing software must also prepare IEC 62304 software lifecycle documentation — the two requirements run in parallel, one does not include the other.

• Scope — active medical devices only;
• Required reports — electrical safety test report and electromagnetic compatibility test report;
• Standard system — IEC 60601 series;
• Software-containing devices additionally require IEC 62304 software lifecycle documentation;
• Testing must be performed at a Myanmar-accredited laboratory (practical estimate).

Note also that this requirement does not stand alone: for class II and III devices, the full performance test report is required in any case, and for active products the electrical safety and EMC reports form part of that overall testing picture. The practical consequence is that the active-device testing workstream should be planned together with the class-specific full performance report, not as a separate afterthought, so that samples, laboratory slots and lead times are coordinated in one schedule.

2. Legal basis

The applicability, the required reports and the associated software and testing obligations are summarised below. Two items are marked as practical estimates because they reflect the currently observed administrative practice rather than a formally published rule: the Ministry of Health’s added declaration requirement and the accredited-laboratory testing expectation. Teams should reconfirm both against the latest official communication before committing a testing budget, since the practical estimate may evolve even while the core IEC 60601 obligation stays stable.

3. Expert insights

Insight 1: active versus passive is the first fork in the document list. Active devices add the electrical safety and electromagnetic compatibility documents; passive devices focus instead on biocompatibility and sterilization validation. Getting the judgment wrong produces either missing documents or unnecessary preparation, so it should be made deliberately and recorded, not assumed from the product family name. The determination also drives the IEC 62304 question, because software content is a separate axis that can cut across both active and passive devices.

Insight 2: the test reports must come from a Myanmar-accredited laboratory. This means foreign test reports may not be directly accepted, and companies must plan the sample submission arrangements and lead time well in advance. Because the testing slot sits on the critical path of the whole registration calendar, booking it late compresses every downstream step, from dossier assembly to the FDA review itself.

Insight 3: electrical safety and electromagnetic compatibility are two parallel requirements. The former concerns the safety of the device itself; the latter concerns how the device behaves in an electromagnetic environment and how it affects other equipment. Neither can substitute for the other, and both reports must exist before the dossier can be considered complete for an active device. They are also normally produced as two distinct test programmes even when performed in the same laboratory, so the sample logistics and the report formats should be negotiated with the laboratory accordingly.

Insight 4: the test reports must close the loop with the risk management file. The risk analysis should identify the electrical and electromagnetic risks, the test reports demonstrate that they are controlled, and the residual risk evaluation concludes on acceptance. This three-step chain is what turns two isolated test reports into coherent technical evidence, and it is the chain reviewers follow when they check whether the electrical documents are merely present or actually integrated.

Insight 5: the software version consistency declaration is an additional threshold for active software-based devices. It must be issued by the legal manufacturer and notarised, confirming that the version distributed in Myanmar is identical to the version verified in the CE technical file. Version drift between these two sets of documentation is exactly the kind of discrepancy that triggers clarification requests, so the declaration should be obtained whenever a distribution version is frozen, not reconstructed afterwards.

4. Practical recommendations

• First determine whether the product is an active device. The electrical and electromagnetic documents follow from this determination.
• Plan the submission to a Myanmar-accredited laboratory early. The testing cycle affects the overall schedule.
• Prepare both the electrical safety and the electromagnetic compatibility reports. One does not replace the other.
• Feed the test results back into the risk management file. Complete the risk-control-verification loop.
• Prepare the notarised version consistency declaration for software products. State the version number precisely.

Taken together, these recommendations push the electrical workstream to the front of the project: the active-versus-passive determination, the laboratory booking and the risk-analysis alignment all happen before dossier assembly, so that by the time the submission date arrives the electrical documents exist, match the risk file and carry no unresolved practical-estimate assumptions.

5. Verification checklist

• □ Determined whether the product is an active medical device
• □ Electrical safety test report obtained
• □ Electromagnetic compatibility test report obtained
• □ Testing institution confirmed as a Myanmar-accredited laboratory
• □ Test results fed back into the risk management file
• □ Notarised version consistency declaration prepared for software-containing products
• □ Electrical file included in the registration register management

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Myanmar. Our team prepares the technical dossier to ASEAN CSDT structure, manages submission and deficiency responses with the Myanmar FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com